Case-ControlMolecular autism2021

How rare and common risk variation jointly affect liability for autism spectrum disorder.

Lambertus Klei, Lora Lee McClain, Behrang Mahjani and 13 others

PMID 34615521

WHAT IT FOUND

ASD subjects carried more common genetic risk than controls.

Rare damaging variants did not replace common risk. Carriers averaged between non-carriers and controls, which fits a combined genetic risk model.

Key findings

01ASD subjects had higher common genetic risk scores than unaffected subjects, whether or not they carried rare damaging variants.

02Among ASD subjects, rare variant carriers had lower common risk scores than non-carriers.

03The average combined risk score in rare variant carriers was close to the midpoint between ASD subjects and unaffected subjects, which suggests rare and common genetic risk combine.

STILL TO COME

How it was doneWhat they found

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study used only European descent samples, so the results may not apply to other ancestry groups. Some people counted as non-carriers may actually carry rare damaging variants because not all autism subjects were fully characterized for rare variants. Some controls were assumed unaffected, but they may have been affected. The number of rare variant carriers was small, so the additive pattern is only a coarse finding. The genetic scores are research tools, not clinical diagnostic tests. The training and testing method could overfit the data, so the authors corrected the significance tests.

Declared interests

The work was supported by the National Institute of Mental Health, the Simons Foundation, and the Beatrice and Samuel A. Seaver Foundation.

The easy way to misread this

Do not read the rare variant carrier pattern as proof that a rare variant alone explains autism. The carriers still had common genetic risk, and the authors say the evidence is far from conclusive.

Read it on PubMed →


The study

Participants
17,972 samples; 3011 ASD subjects and 14,961 unaffected subjects; 3011 matched pairs analyzed
Certainty of evidence
Low

Browse

    Cite

    Lambertus Klei, Lora Lee McClain, Behrang Mahjani, et al. How rare and common risk variation jointly affect liability for autism spectrum disorder. Molecular autism. 2021.

    Read the original